Colorimetric immunoassay for detection of tumor markers

International Journal of Molecular Sciences

Volumn 11, Issue 12, 2010, Pages 5077-5094

  Yin, Yongmei ^a   Cao, Ya ^b   Xu, Yuanyuan ^b   Li, Genxi ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY   (China)

Author keywords

Colorimetric immunoassay; Nanomaterials; Tumor markers

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; OLIGONUCLEOTIDE; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN; STREPTAVIDIN; THIOL DERIVATIVE; TUMOR MARKER; TUMOR PROTEIN;

ANALYTIC METHOD; ANTIBODY DETECTION; CANCER DIAGNOSIS; CHEMICAL LABELING; CHEMICAL MODIFICATION; COLORIMETRC IMMUNOASSAY; COLORIMETRY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA BARCODING; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; HUMAN; IMMUNOASSAY; MATERIAL COATING; NANOTECHNOLOGY; REVIEW; SYNTHESIS; IMMUNOLOGY; PROCEDURES;

COLORIMETRY; HUMANS; IMMUNOASSAY; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650988822     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11125077     Document Type: Review

References (85)

1. World Healther Organization. Cancer. Available online: http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed on 25 November 2007).
2. Reid, B.J.; Weinstein, W.M.; Lewin, K.J.; Haggitt, R.C.; van Deventer, G.; DenBesten, L.; Rubin, C.E. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988, 6, 81-90.
3. Wahl, R.L.; Quint, L.E.; Greenough, R.L.; Meyer, C.R.; White, R.I.; Orringer, M.B. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology 1994, 191, 371-377.
4. Beyer, T.; Townsend, D.W.; Brun, T.; Kinahan, P.E.; Charron, M.; Roddy, R.; Jerin, J.; Young, J.; Byars, L.; Nutt, R. A combined PET/CT scanner for clinical oncology. J. Nucl. Med. 2000, 41, 1369-1379.
5. Kircher, M.F.; Mahmood, U.; King, R.S.; Weissleder, R.; Josephson, L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003, 63, 8122-8125.
6. Choi, Y.E.; Kwak, J.W.; Park, J.W. Nanotechnology for early cancer detection. Sensors 2010, 10, 428-455.
7. Safi, F.; Kohler, I.; Rottinger, E.; Beger, H. The value of the tumor marker CA15-3 in diagnosing and monitoring breast cancer. Cancer 1991, 68, 574-582.
8. Harris, L.; Fritsche, H.; Mennel, R.; Norton, L.; Ravdin, P.; Taube, S.; Somerfield, M.R.; Hayes, D.F.; Bast, R.C., Jr. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 2007, 25, 5287-5312.
9. Kumar, S.; Mohan, A.; Guleria, R. Biomarkers in cancer screening, research and detection: Present and future: A review. Biomarkers 2006, 11, 385-405.
10. Hanash, S.; Pitteri, S.; Faca, V. Mining the plasma proteome for cancer biomarkers. Nature 2008, 452, 571-579.
11. Chen, D.S.; Sung, J.L. Serum alpha-fetoprotein in hepatocellular carcinoma. Cancer 1977, 40, 779-783.
12. Canney, P.A.; Moore, M.; Wilkinson, P.M.; James, R.D. Ovarian cancer antigen CA125: A prospective clinical assessment of its role as a tumour marker. Br. J. Cancer 1984, 50, 765-769.
13. Benchimol, S.; Fuks, A.; Jothy, S.; Beauchemin, N.; Shirota, K.; Stanners, C.P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989, 57, 327-334.
14. Osborne, C.K.; Yochmowitz, M.G.; Knight, W.A., 3rd; McGuire, W.L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980, 46, 2884-2888.
15. Jacobsen, G.K.; Jacobsen, M. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours: A prospective immunohistochemical study. Acta Pathol. Microbiol. Immunol. Scand. A 1983, 91, 165-176.
16. Horton, J. Her2 and Trastuzumab in breast cancer. Cancer Control 2001, 8, 103-110.
17. Lilja, H.; Ulmert, D.; Vickers, A.J. Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring. Nat. Rev. Cancer 2008, 8, 497-511.
18. Stamey, T.A.; Yang, N.; Hay, A.R.; McNeal, J.E.; Freiha, F.S.; Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 1987, 317, 909-916.
19. Catalona, W.J.; Smith, D.S.; Ratliff, T.L.; Dodds, K.M.; Coplen, D.E.; Yuan, J.J.; Petros, J.A.; Andriole, G.L. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991, 324, 1156-1161.
20. Dhanasekaran, S.M.; Barrette, T.R.; Ghosh, D.; Shah, R.; Varambally, S.; Kurachi, K.; Pienta, K.J.; Rubin, M.A.; Chinnaiyan, A.M. Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412, 822-826.
21. Bates, S.E. Clinical applications of serum tumor markers. Ann. Int. Med. 1991, 115, 623-638.
22. Carter, P.; Presta, L.; Gorman, C.M.; Ridgway, J.B.; Henner, D.; Wong, W.L.; Rowland, A.M.; Kotts, C.; Carver, M.E.; Shepard, H.M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 1992, 89, 4285-4289.
23. Bast, R.C.; Bates, S.; Bredt, A.B.; Desch, C.E.; Fritsche, H.; Fues, L.; Hayes, D.F.; Kemeny, N.E.; Kragen, M.; Jessup, J.; Locker, G.Y.; Macdonald, J.S.; Mennel, R.G.; Norton, L.; Ravdin, P.; Smith, T.J; Taube, S.; Winn, R.J. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J. Clin. Oncol. 1996, 14, 2843-2877.
24. Sok, D.; Clarizia, L.; Farris, L.; McDonald, M. Novel fluoroimmunoassay for ovarian cancer biomarker CA-125. Anal. Bioanal. Chem. 2009, 393, 1521-1523.
25. Wilson, M.S.; Nie, W. Multiplex measurement of seven tumor markers using an electrochemical protein chip. Anal. Chem. 2006, 78, 6476-6483.
26. Li, C.; Curreli, M.; Lin, H.; Lei, B.; Ishikawa, F.N.; Datar, R.; Cote, R.J.; Thompson, M.E.; Zhou, C. Complementary detection of prostate-specific antigen using In2O3 nanowires and carbon nanotubes. J. Am. Chem. Soc. 2005, 127, 12484-12485.
27. Nam, J.M.; Thaxton, C.S.; Mirkin, C.A. Nanoparticle-based bio-barcodes for the ultrasensitive detection of proteins. Science 2003, 301, 1884-1886.
28. Zheng, G.; Patolsky, F.; Cui, Y.; Wang, W.U.; Lieber, C.M. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol. 2005, 23, 1294-1301.
29. Nam, J.M.; Wise, A.R.; Groves, J.T. Colorimetric bio-barcode amplification assay for cytokines. Anal. Chem. 2005, 77, 6985-6988.
30. Zhao, Y.; Zhao, X.; Hu, J.; Xu, M.; Zhao, W.; Sun, L.; Zhu, C.; Xu, H.; Gu, Z. Encoded porous beads for label-free multiplex detection of tumor markers. Adv. Mater. 2008, 20, 1-4.
31. Liu, X.; Dai, Q.; Austin, L.; Coutts, J.; Knowles, G.; Zou, J.; Chen, H.; Huo, Q. A One-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. J. Am. Chem. Soc. 2008, 130, 2780-2782.
32. Stoeva, S.I.; Lee, J.S.; Smith, J.E.; Rosen, S.T.; Mirkin, C.A. Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. J. Am. Chem. Soc. 2006, 128, 8378-8379.
33. Oh, B.K.; Nam, J.M.; Lee, S.W.; Mirkin, C.A. A fluorophore-based bio-barcode amplification assay for proteins. Small 2006, 2, 103-108.
34. Wu, G.; Datar, R.H.; Hansen, K.M.; Thundat, T.; Cote, R.J.; Majumdar, A. Bioassay of prostate- specific antigen (PSA) using microcantilevers. Nat. Biotechnol. 2001, 19, 856-860.
35. Mani, V.; Chikkaveeraiah, B.V.; Patel, V.; Gutkind, J.S.; Rusling, J.F. Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification. ACS Nano 2009, 3, 585-594.
36. Yu, X.; Munge, B.; Patel, V.; Jensen, G.; Bhirde, A.; Gong, J.D.; Kim, S.N.; Gillespie, J.; Gutkind, J.S.; Papadimitrakopoulos, F.; Rusling, J.F. Carbon nanotube amplification strategies for highly sensitive immunodetection of cancer biomarkers. J. Am. Chem. Soc. 2006, 128, 11199-11205.
37. Grubisha, D.S.; Lipert, R.J.; Park, H.Y.; Driskell, J.; Porter, M.D. Femtomolar detection of prostate-specific antigen: An immunoassay based on surface-enhanced Raman scattering and immunogold labels. Anal. Chem. 2003, 75, 5936-5943.
38. Cao, C.; Li, X.; Lee, J.; Sim, S.J. Homogenous growth of gold nanocrystals for quantification of PSA protein biomarker. Biosens. Bioelectron. 2009, 24, 1292-1297.
39. Ao, L.; Gao, F.; Pan, B.; He, R.; Cui, D. Fluoroimmunoassay for antigen based on fluorescence quenching signal of gold nanoparticles. Anal. Chem. 2006, 78, 1104-1106.
40. Lee, J.R.; Lee, J.; Kim, S.K.; Kim, K.P.; Park, H.S.; Yeo, W.S. Mass spectrometry signal amplification method for attomolar detection of antigens using small-molecule-tagged gold microparticles. Angew. Chem. Int. Ed. 2008, 47, 9518-9521.
41. Li, N.; Yuan, R.; Chai, Y.; Chen, S.; An, H.; Li, W. New antibody immobilization strategy based on gold nanoparticles and azure I/multi-walled carbon nanotube composite membranes for an amperometric enzyme immunosensor. J. Phys. Chem. C 2007, 111, 8443-8450.
42. Bi, S.; Zhou, H.; Zhang, S. Multilayers enzyme-coated carbon nanotubes as biolabel for ultrasensitive chemiluminescence immunoassay of cancer biomarker. Biosens. Bioelectron. 2009, 24, 2961-2966.
43. Lee, Y.M.; Jeong, Y.; Kang, H.J.; Chung, S.J.; Chung, B.H. Cascade enzyme-linked immunosorbent assay (CELISA). Biosens. Bioelectron. 2009, 25, 332-337.
44. Zhou, W.H.; Zhu, C.L.; Lu, C.H.; Guo, X.; Chen, F.; Yang, H.H.; Wang, X. Amplified detection of protein cancer biomarkers using DNAzyme functionalized nanoprobes. Chem. Commun. 2009, 44, 6845-6847.
45. Wang, J.; Cao, Y.; Xu, Y.; Li, G. Colorimetric multiplexed immunoassay for sequential detection of tumor markers. Biosens. Bioelectron. 2009, 25, 532-536.
46. Fu, Z.; Liu, H.; Ju, H. Flow-through multianalyte chemiluminescent immunosensing system with designed substrate zone-resolved technique for sequential detection of tumor markers. Anal. Chem. 2006, 78, 6999-7005.
47. Ou, C.; Yuan, R.; Chai, Y.; Tang, M.; Chai, R.; He, X. A novel amperometric immunosensor based on layer-by-layer assembly of gold nanoparticlesmulti-walled carbon nanotubes-thionine multilayer films on polyelectrolyte surface. Anal. Chim. Acta 2007, 603, 205-213.
48. Chon, H.; Lee, S.; Son, S.W.; Oh, C.H.; Choo, J. Highly sensitive immunoassay of lung cancer marker carcinoembryonic antigen using surface-enhanced raman scattering of hollow gold nanosperes. Anal. Chem. 2009, 81, 3029-3034.
49. Liu, M.; Jia, C.; Huang, Y.; Lou, X.; Yao, S.; Jin, Q.; Zhao, J.; Xiang, J. Highly sensitive protein detection using enzyme-labeled gold nanoparticle probes. Analyst 2010, 135, 327-331.
50. 2+ heavy metal ions using Au nanoparticles. Anal. Bioanal. Chem. 2009, 394, 33-46.
51. Ohno, Y. CIE fundamentals for color measurements. IS&T NIP16 Intl. Conf. on Digital Printing Technologies: Vancouver, Canada, 2000; pp. 540-545
52. Zangar, R.C.; Daly, D.S.; White, A.M. ELISA microarray technology as a high-throught system for cancer biomarker validation. Expert Rev. Proteomics 2006, 3, 37-44.
53. Lequin, R.M. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clin. Chem. 2005, 51, 2415-2418.
54. Leng, S.; McElhaney, J.; Walston, J.; Xie, D.; Fedarko, N.; Kuchel, G. Elisa and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63, 879-884.
55. Cook, D.B.; Bustamam, A.A.; Brotherick, I.; Shenton, B.K.; Self, C.H. Lectin ELISA for the c-erb-B2 tumor marker protein p185 in patients with breast cancer and controls. Clin. Chem. 1999, 45, 292-295.
56. Zehentner, B.K.; Persing, D.H.; Deme, A.; Toure, P.; Hawes, S.E.; Brooks, L.; Feng, Q.; Hayes, D.C.; Critichlow, C.W.; Houghton, R.L.; Kiviat, N.B. Mammaglobin as a novel breast cancer biomarker: Multigene reverse transcription-PCR assay and sandwich ELISA. Clin. Chem. 2004, 50, 2069-2076.
57. Prasad, P.V.; Chaube, S.K.; Shrivastav, T.G.; Kumari, G.L. Development of colorimetric enzyme-linked immunosorbent assay for human chorionic gonadotropin. J. Immunoassay Immunochem. 2006, 27, 15-30.
58. Ambrosi, A.; Airò, F.; Merkoçi, A. Enhanced gold nanoparticle based ELISA for a breast cancer biomarker. Anal. Chem. 2010, 82, 1151-1156.
59. Liu, Y.; Wang, H.; Huang, J.; Yang, J.; Liu, B.; Yang, P. Microchip-based ELISA strategy for the detection of low-level disease biomarker in serum. Anal. Chim. Acta 2009, 650, 77-82.
60. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
61. Chen, H.; Jiang, C.; Yu, C.; Zhang, S.; Liu, B.; Kong, J. Protein chips and nanomaterials for application in tumor marker immunoassays. Biosens. Bioelectron. 2009, 24, 3399-3411.
62. Gomez-Hens, A.; Fernandez-Romero, J.M.; Aguilar-Caballos, M.P. Control of tumor markers using nanotechnology. Mini-Rev. Med. Chem. 2009, 9, 1064-1074.
63. Kim, D.; Daniel, W.L.; Mirkin, C.A. Microarray-based multiplexed scanometric immunoassay for protein cancer markers using gold nanoparticle probes. Anal. Chem. 2009, 81, 9183-9187.
64. Ling, J.; Li, Y.F.; Huang, C.Z. Visual sandwich immunoassay system on the basis of plasmon resonance scattering signals of silver nanoparticles. Anal. Chem. 2009, 81, 1707-1714.
65. Piao, Y.; Lee, D.; Kim, J.; Kim, J.; Hyeon, T.; Kim, H.S. High performance immunoassay using immobilized enzyme in nanoporous carbon. Analyst 2009, 134, 926-932.
66. Lu, W.; Arumugam, S.R.; Senapati, D.; Singh, A.K.; Arbneshi, T.; Khan, S.A.; Yu, H.; Ray, P.C. Multifunctional oval-shaped gold nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two photon scattering assay. ACS Nano 2010, 4, 1739-1749.
67. Tan, Y.N.; Su, X.; Liu, E.T.; Thomsen, J.S. Gold-nanoparticle-based assay for instantaneous detection of nuclear hormone receptor-response elements interactions. Anal. Chem. 2010, 82, 2759-2765.
68. Nam, J.M.; Jang, K.J.; Groves, J.T. Detection of proteins using a colorimetric bio-barcode assay. Nat. Protoc. 2007, 2, 1438-1444.
69. Liu, Y.; Liu, Y.; Mernaugh, R.L.; Zeng, X. Single chain fragment variable recombinant antibody functionalized gold nanoparticles for a highly sensitive colorimetric immunoassay. Biosens. Bioelectron. 2009, 24, 2853-2857.
70. Liu, M.; Jia, C.; Jin, Q.; Lou, X.; Yao, S.; Xiang, J.; Zhao, J. Novel colorimetric enzyme immunoassay for the detection of carcinoembryonic antigen. Talanta 2010, 81, 1625-1629.
71. de Dios, A.S.; Díaz-García, M.E. Multifunctional nanoparticles: Analytical prospects. Anal. Chim. Acta 2010, 666, 1-22.
72. Stanciu, L.; Won, Y.H.; Ganesana, M.; Andreescu, S. Magnetic Particle-Based Hybrid Platforms for Bioanalytical Sensors. Sensors 2009, 9, 2976-2999.
73. Hsing, I.M.; Xu, Y.; Zhao, W.T. Micro- and nano-magnetic particles for applications in biosensing. Electroanalysis 2007, 19, 755-768.
74. Sandwich ELISA Protocol: General procedure and tips for Sandwich ELISA including details of how to find matched pair antibodies. Abcam: Hong Kong, China. Available at: http://www.abcam.cn/index.html?pageconfig=resource&rid=11422 (accessed on 25 November 2010).
75. Huang, C.C.; Huang, Y.F.; Cao, Z.; Tan, W.; Chang, H.T. Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal. Chem. 2005, 77, 5735-5741.
76. Faulk, W.P.; Taylor, G.M. An immunocolloid method for the electron microscope. Immunochemistry 1971, 8, 1081-1083.
77. Qian, X.; Peng, X.H.; Ansari, D.O.; Yin-Goen, Q.; Chen, G.Z.; Shin, D.M.; Yang, L.; Young, A.N.; Wang, M.D.; Nie, S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 2008, 26, 83-90.
78. Niemeyer, C.M.; Ceyhan, B. DNA-directed functionalization of colloidal gold with proteins. Angew. Chem. Int. Ed. 2001, 40, 3685-3688.
79. Chen, Y.H.; Tsai, C.Y.; Huang, P.Y.; Chang, M.Y.; Cheng, P.C.; Chou, C.H.; Chen, D.H.; Wang, C.R.; Shiau, A.L.; Wu, C.L. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm. 2007, 4, 713-722.
80. Ferreira, C.S.; Papamichael, K.; Guilbault, G.; Schwarzacher, T.; Gariepy, J.; Missailidis, S. DNA aptamers against the MUC1 tumour marker: Design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours. Anal. Bioanal. Chem. 2008, 390, 1039-1050.
81. Lupold, S.E.; Hicke, B.J.; Lin, Y.; Coffey, D.S. Identification and characterization of nuclease- stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002, 62, 4029-4033.
82. Kim, E.; Seo, S.; Seo, M.L.; Jung, J.H. Functionalized monolayers on mesoporous silica and on titania nanoparticles for mercuric sensing. Analyst 2010, 135, 149-156.
83. Song, Y.; Wang, X.; Zhao, C.; Qu, K.; Ren, J.; Qu, X. Label-free colorimetric detection of single nucleotide polymorphism by using single-walled carbon nanotube intrinsic peroxidase-like activity. Chem. Eur. J. 2010, 16, 3617-3621.
84. Chen, Z.; He, Y.; Luo, S.; Lin, H.; Chen, Y.; Sheng, P.; Li, J.; Chen, B.; Liu, C.; Cai, Q. Label-free colorimetric assay for biological thiols based on ssDNA/silver nanoparticle system by salt amplification. Analyst 2010, 135, 1066-1069.
85. Wu, J.; Fu, Z.; Yan, F.; Ju, H. Biomedical and clinical applications of immunoassays and immunosensors for tumor markers. Trends Anal. Chem. 2007, 26, 679-688.